ArticleJournal of human genetics2026
Variable phenotypic manifestations of two splice-site variants in DNAJB2: insights from two families and a systematic review.
Article in Journal of human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
DNAJB2 encodes an HSP40 co‑chaperone involved in protein quality control and maintenance of neuronal proteostasis. Pathogenic variants in this gene, typically inherited in an autosomal recessive manner, cause hereditary motor neuropathy (HMN), Charcot-Marie-Tooth disease (CMT), and other neuromuscular disorders. In this study, we report two unrelated families harboring two distinct splice-site variants within the same intron of DNAJB2: one affecting the acceptor site and the other the donor site, identified in patients presenting with HMN and CMT, respectively. We also performed a systematic review of previously reported variants to further investigate phenotypic variabilities and likely genotype-phenotype correlations. Whole‑exome sequencing (WES) was performed for probands with clinical diagnosis of hereditary neuropathy. Identified variants were confirmed by Sanger sequencing, and co‑segregation analysis was conducted within the families. A systematic review was performed following PRISMA 2020 guidelines using PubMed, Scopus, and Google Scholar databases (January 2000-May 2026). WES identified a known variant, c.446‑1 G > C, in one proband and a novel one, c.445+1del, in another. Clinically, the first patient showed an HMN phenotype, whereas the second presented with an axonal CMT (CMT2). In total, 25 distinct DNAJB2 variants were identified across 46 families in the literature, with most occurring in the homozygous state. Our study expands the mutational spectrums of this gene, and the systematic evaluation of DNAJB2-related cases demonstrates the marked clinical heterogeneity but not a significant genotype-phenotype correlation.
Identifiers
42806108What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.